Inflammation and age-related macular degeneration (AMD)

Seminars in Ophthalmology

Volumn 26, Issue 3, 2011, Pages 192-197

  Telander, David G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

age related macular degeneration (AMD); complement; drusen; Factor H gene; immune system; inflammation; pathogenesis; retinal degeneration

Indexed keywords

ALPHA CRYSTALLIN; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ANECORTAVE; APOLIPOPROTEIN E; APTAMER; ARC 1905; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; COMPLEMENT INHIBITOR; COMPLEMENT MEMBRANE ATTACK COMPLEX; CORTICOSTEROID; DEXAMETHASONE; ECULIZUMAB; FLUOCINOLONE ACETONIDE; GLATIRAMER; GLIAL FIBRILLARY ACIDIC PROTEIN; ILLUVIEN; INFLIXIMAB; JPE 1375; JSM 6427; LIPOCORTIN 2; LIPOFUSCIN; MAMMALIAN TARGET OF RAPAMYCIN; MONOCYTE CHEMOTACTIC PROTEIN 1; POT 4; RAPAMYCIN; SOLLIRIS; UNCLASSIFIED DRUG; VASCULOTROPIN;

ALZHEIMER DISEASE; BRUCH MEMBRANE; CELL PROLIFERATION; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; DNA ADDUCT; DRUSEN; EXTRACELLULAR MATRIX; EYE INFLAMMATION; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; OXIDATIVE STRESS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RETINA INJURY; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK FACTOR; SUBRETINAL NEOVASCULARIZATION; VISUAL IMPAIRMENT;

COMPLEMENT FACTOR H; HUMANS; IMMUNE SYSTEM; INFLAMMATION; MACULAR DEGENERATION; RETINITIS; RISK FACTORS;

EID: 79957619481     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.3109/08820538.2011.570849     Document Type: Review

References (57)

1. Seddon JM, Chen CA. The epidemiology of age-related macular degeneration. Int Ophthalmol Clin 2004; 44:17-39. (Pubitemid 39392076)
2. Rodrigues EB. Inflammation in dry age-related macular degeneration. Ophthalmologica 2007; 221:143-52. (Pubitemid 46631914)
3. Bonifati DM, Kishore U. Role of complement in neurodegeneration and neuroinflammation. Mol Immunol 2007; 44:999-1010. (Pubitemid 44414994)
4. Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 2000; 14:835-46.
5. Wang JJ, Foran S, Smith W, Mitchell P. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: The Blue Mountains Eye Study cohort. Arch Ophthalmol 2003; 121:658-63. (Pubitemid 36554468)
6. Kini MM, Leibowitz HM, Colton T, Nickerson RJ, Ganley J, Dawber TR. Prevalence of senile cataract, diabetic retinopathy, senile macular degeneration, and open-angle glaucoma in the Framingham eye study. Am J Ophthalmol 1978; 85:28-34. (Pubitemid 8267281)
7. Kornzweig AL. Macular Diseases: Pathogenesis. Diseases of the macula in the aged. Trans Am Acad Ophthalmol Otolaryngol 1965; 69:668-82.
8. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology 2001; 108:697-704. (Pubitemid 32238465)
9. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001; 20:705-32. (Pubitemid 32918285)
10. Donoso LA, Kim D, Frost A, Callahan A, Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2006; 51:137-52. (Pubitemid 43269939)
11. Anderson DH, Talaga KC, Rivest AJ, Barron E, Hageman GS, Johnson LV. Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp Eye Res 2004; 78:243-56. (Pubitemid 38077231)
12. Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH. The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci U S A 2002; 99:11830-5. (Pubitemid 34994484)
13. Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 2002; 134:411-31.
14. Colville D, Guymer R, Sinclair RA, Savige J. Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II ("dense deposit disease"). Am J Kidney Dis 2003; 42:E2-5.
15. Framme C, Herboth T, Roider J, Laqua H. [Subretinal neovascular membranes in membranoproliferative glomerulonephritis type II]. Klin Monbl Augenheilkd 1998; 213:252-3. (Pubitemid 28516898)
16. Huang SJ, Costa DL, Gross NE, Yannuzzi LA. Peripheral drusen in membranoproliferative glomerulonephritis type II. Retina 2003; 23:429-31. (Pubitemid 36793003)
17. McGeer PL, McGeer EG. Inflammation and the degenerative diseases of aging. Ann N Y Acad Sci 2004; 1035:104-16. (Pubitemid 40362329)
18. Zarbin MA. Current concepts in the pathogenesis of agerelated macular degeneration. Arch Ophthalmol 2004; 122:598-614. (Pubitemid 38456297)
19. Frank RN, Amin RH, Puklin JE. Antioxidant enzymes in the macular retinal pigment epithelium of eyes with neovascular age-related macular degeneration. Am J Ophthalmol 1999; 127:694-709. (Pubitemid 29266746)
20. Crabb JW, Miyagi M, Gu X, et al. Drusen proteome analysis: An approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A 2002; 99:14682-7. (Pubitemid 35334544)
21. Johnson LV, Leitner WP, Staples MK, Anderson DH. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp Eye Res 2001; 73:887-96. (Pubitemid 34112114)
22. Nozaki M, Raisler BJ, Sakurai E, et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci U S A 2006; 103:2328-33. (Pubitemid 43271669)
23. Blom AM, Kask L, Ramesh B, Hillarp A. Effects of zinc on factor I cofactor activity of C4b-binding protein and factor H. Arch Biochem Biophys 2003; 418:108-18. (Pubitemid 37159377)
24. Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/ CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 2005; 102:7227-32. (Pubitemid 40696361)
25. Hageman GS, Hancox LS, Taiber AJ, et al. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann Med 2006; 38:592-604. (Pubitemid 46292019)
26. Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, Chakravarthy U. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet 2006; 38:1173-7. (Pubitemid 44470363)
27. Karagianni N, Adamis AP. The case for complement and inflammation in AMD: open questions. Adv Exp Med Biol 2010; 703:1-7.
28. Markiewski MM, Lambris JD. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol 2007; 171:715-27. (Pubitemid 47440971)
29. Meri S. Loss of self-control in the complement system and innate autoreactivity. Ann N Y Acad Sci 2007; 1109:93-105. (Pubitemid 47511348)
30. Moshfeghi DM, Blumenkranz MS. Role of genetic factors and inflammation in age-related macular degeneration. Retina 2007; 27:269-75. (Pubitemid 46398891)
31. Swaroop A, Branham KE, Chen W, Abecasis G. Genetic susceptibility to age-related macular degeneration: A paradigm for dissecting complex disease traits. Hum Mol Genet 2007; 16 Spec No. 2:R174-82.
32. Anderson DH, Radeke MJ, Gallo NB, et al. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 2010;29:95-112.
33. Wu Z, Lauer TW, Sick A, Hackett SF, Campochiaro PA. Oxidative stress modulates complement factor H expression in retinal pigmented epithelial cells by acetylation of FOXO3. J Biol Chem 2007; 282:22414-25. (Pubitemid 47267308)
34. Gold B, Merriam JE, Zernant J, et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006; 38:458-62.
35. Gurne DH, Tso MO, Edward DP, Ripps H. Antiretinal antibodies in serum of patients with age-related macular degeneration. Ophthalmology 1991; 98:602-7.
36. Penfold PL, Madigan MC, Provis JM. Antibodies to human leucocyte antigens indicate subpopulations of microglia in human retina. Vis Neurosci 1991; 7:383-8.
37. de Smet MD, Chan CC. Regulation of ocular inflammation- what experimental and human studies have taught us. Prog Retin Eye Res 2001; 20:761-97. (Pubitemid 32923071)
38. Morohoshi K, Goodwin AM, Ohbayashi M, Ono SJ. Autoimmunity in retinal degeneration: autoimmune retinopathy and age-related macular degeneration. J Autoimmun 2009; 33:247-54.
39. Patel N, Ohbayashi M, Nugent AK, et al. Circulating antiretinal antibodies as immune markers in age-related macular degeneration. Immunology 2005; 115:422-30. (Pubitemid 40896040)
40. Penfold PL, Provis JM, Furby JH, Gatenby PA, Billson FA. Autoantibodies to retinal astrocytes associated with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1990; 228:270-4. (Pubitemid 20150313)
41. de Jong PT. Age-related macular degeneration. N Engl J Med 2006; 355:1474-85. (Pubitemid 44511562)
42. van der Schaft TL, Mooy CM, de Bruijn WC, de Jong PT. Early stages of age-related macular degeneration: an immunofluorescence and electron microscopy study. Br J Ophthalmol 1993; 77:657-61. (Pubitemid 23298389)
43. Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res 2001; 20:385-414. (Pubitemid 32245687)
44. Grossniklaus HE, Ling JX, Wallace TM, et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis 2002; 8:119-26. (Pubitemid 36153599)
45. Jonas JB, Tao Y, Neumaier M, Findeisen P. Monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 in exudative age-related macular degeneration. Arch Ophthalmol 2010; 128:1281-6.
46. Tuo J, Bojanowski CM, Chan CC. Genetic factors of agerelated macular degeneration. Prog Retin Eye Res 2004; 23:229-49. (Pubitemid 38496402)
47. Tuo J, Smith BC, Bojanowski CM, et al. The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J 2004; 18:1297-9. (Pubitemid 39561582)
48. Kalayoglu MV, Galvan C, Mahdi OS, Byrne GI, Mansour S. Serological association between Chlamydia pneumoniae infection and age-related macular degeneration. Arch Ophthalmol 2003; 121:478-82. (Pubitemid 36427634)
49. Miller DM, Espinosa-Heidmann DG, Legra J, et al. The association of prior cytomegalovirus infection with neovascular age-related macular degeneration. Am J Ophthalmol 2004; 138:323-8. (Pubitemid 39208558)
50. Kalayoglu MV, Bula D, Arroyo J, Gragoudas ES, D'Amico D, Miller JW. Identification of Chlamydia pneumoniae within human choroidal neovascular membranes secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2005; 243:1080-90. (Pubitemid 43124158)
51. Zarbin M. Should corticosteroids be considered as part of the standard care with photodynamic therapy? Arch Ophthalmol 2006; 124:563-71.
52. Landa G, Butovsky O, Shoshani J, Schwartz M, Pollack A. Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration. Curr Eye Res 2008; 33:1011-3.
53. Aizuss DH, Mondino BJ, Sumner HL, Dethlefs BA. The complement system and host defense against Pseudomonas endophthalmitis. Invest Ophthalmol Vis Sci 1985; 26:1262-6. (Pubitemid 15237917)
54. Giese MJ, Mondino BJ, Glasgow BJ, et al. Complement system and host defense against staphylococcal endophthalmitis. Invest Ophthalmol Vis Sci 1994; 35:1026-32. (Pubitemid 24079834)
55. Joachim SC, Bruns K, Lackner KJ, Pfeiffer N, Grus FH. Analysis of IgG antibody patterns against retinal antigens and antibodies to alpha-crystallin, GFAP, and alpha-enolase in sera of patients with "wet" age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2007; 245:619-26. (Pubitemid 46951226)
56. Umeda S, Suzuki MT, Okamoto H, et al. Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis). FASEB J 2005; 19:1683-5. (Pubitemid 41429529)
57. Gu X, Meer SG, Miyagi M, et al. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J Biol Chem 2003; 278:42027-35. (Pubitemid 37310467)